Products
B2B Zone
3rd Molecular Glue Drug Development Summit
3rd Molecular Glue Drug Development Summit
Conferences

3rd Molecular Glue Drug Development Summit

By

Hanson Wade

2 Followers
28 Jan 2025 - 30 Jan 2025
Free Registration

Event Details

3rd Molecular Glue Drug Development Summit

Molecular glue development continues to thrive, offering exciting opportunities to target previously undruggable proteins and treat a wide range of diseases. 2024 has seen a multitude of collaborations, with Takeda and Degron Therapeutics entering a deal worth $1.2 billion.

The 3rd Molecular Glue Drug Development Summit returns as the only industry-dedicated forum bringing together 90+ experts as they showcase the latest advancements and breakthroughs in molecular glue drug development through discussions and data-driven case studies on screening tools, novel mechanisms of actions of proximity-based degrading and non-degrading molecular glues and lead optimization strategies, to streamline discovery and development of safe and effective glues.

URLs:
Website: https://go.evvnt.com/2697860-0?pid=10018
Tickets: https://go.evvnt.com/2697860-2?pid=10018
Brochure: https://go.evvnt.com/2697860-3?pid=10018

Prices:
Drug Developer Pricing - Full Access Pass (Conference + 2 Workshops): USD 4197.00,
Drug Developer Pricing - 3 Day Pass (Conference + 1 Workshop): USD 3598.00,
Drug Developer Pricing - 2 Day Pass (Conference Only): USD 2999.00,
Academic Pricing - Full Access Pass (Conference + 2 Workshops): USD 3597.00,
Academic Pricing - 3 Day Pass (Conference + 1 Workshop): USD 3098.00,
Academic Pricing - 2 Day Pass (Conference Only): USD 2599.00,
Service and Solution Provider Pricing - Full Access Pass (Conference + 2 Workshops): USD 5097.00,
Service and Solution Provider Pricing - 3 Day Pass (Conference + 1 Workshop): USD 4398.00,
Service and Solution Provider Pricing - 2 Day Pass (Conference Only): USD 3699.00

Speakers: Andres Hernandez, de la Pena Principal Scientist, Neomorph, Andrew Potterton, Head of Technology Platform, Adhesion Therapeutics, Benedict Cross, Chief Technology Officer and Head of Platform, PhoreMost, Bin Liu, Chief Executive Officer, HB Therapeutics, Inc., Bradlee Heckmann, Co-founder and Chief Scientific Officer, ASHA therapeutics, Dmitri Ivanov, Associate Professor Biochemistry and Structural Biology, University of Texas Health San Antonio, Dong Seok Kim, Chief Executive Officer, AevisBio Inc., Fan Liu, Co-Founder and Chief Technology Officer, NeoX Biotech Inc., Felix Hausch Professor, Technical University of Darmstadt, Feng Wang, Senior Principal Scientist and Lab Head Protein Homeostasis Discovery Sciences, Pfizer, Jacob Hale, Senior Scientist, Novartis, Julia Dou, Director of Protein Chemistry, Degron Therapeutics, Markus Queisser, Scientific Director, GlaxoSmithKline Plc, Matthew Hayward, Vice President of Drug Discovery, Magnet Biomedicine, Matthias Brand, Chief Technology Officer, Proxygen GmbH, Meizhong Jin, Senior Director - Oncology Chemistry, AstraZeneca, Peggy Thompson, Vice President and Head of Biology, Plexium Inc., Rana Quraishi, Chief Executive Officer, Isoprene Pharmaceuticals, Rick Ewing, Vice President and Head of Chemistry, Rapafusyn Pharmaceuticals, Tauseef Butt, President and Chief Executive Officer, Progenra, Vivek Vishnudas, Vice President - Drug Discovery Non Clinical Development, Chief Technology Officer, Site Head of Research and Development, BPGBio Inc., Yao Wang, Chief Medical Officer, Kangpu Biopharmaceuticals

Entry Fees

Free Registration

Categories

Event Frequency

One Time

Event Timings

(GMT-5:00) Central Time (US and Canada)
08:00 AM - 04:45 PM (Jan 28, Jan 29, Jan 30) (General)

Speakers

Andres Hernandez
Andres Hernandez
de la Pena Principal Scientist, Neomorph
Andrew Potterton
Andrew Potterton
Head of Technology Platform, Adhesion Therapeutics
Benedict Cross
Benedict Cross
Chief Technology Officer and Head of Platform, PhoreMost
Bin Liu
Bin Liu
Chief Executive Officer, HB Therapeutics, Inc.

Comments on 3rd Molecular Glue Drug Development Summit

You must to write a comment.

Peoples Interested in Visit

0 Peoples Interested to Visit

Event Location

The Royal Sonesta Boston
40, Edwin H Land Boulevard, East Cambridge, Cambridge ,
Middlesex County 02142, Massachusetts, United States
Official Link :

More Events By Organizer

Carbon Accounting in Agricultural Supply Chains
Carbon Accounting in Agricultural Supply Chains
12
Nov
2024
Free
Conferences
7th Lab Asset and Facility Management Summit
7th Lab Asset and Facility Management Summit
18
Nov
2024
Free
Conferences
2nd Covalent Drug Discovery and Development Summit
2nd Covalent Drug Discovery and Development Summit
10
Dec
2024
Free
Conferences
Raw Materials for Cell and Gene Therapy Summit
Raw Materials for Cell and Gene Therapy Summit
13
Nov
2024
Free
Conferences
Personalized Cancer Vaccine Summit
Personalized Cancer Vaccine Summit
03
Dec
2024
Free
Conferences
2nd LNP Characterization and Analytical Development Summit
2nd LNP Characterization and Analytical Development Summit
06
Nov
2024

Similar Events

Molecular Glue Drug Development Summit 2024
Molecular Glue Drug Development Summit 2024
24
Jan
2024
Free
Conferences
Peptide Based Therapeutics Summit
Peptide Based Therapeutics Summit
23
Apr
2024
Free
Conferences
GPCRs-Targeted Drug Discovery Summit Europe
GPCRs-Targeted Drug Discovery Summit Europe
26
Nov
2024

GPCRs-Targeted Drug Discovery Summit Europe

Greater London, United Kingdom
Free
Conferences
7th RNA-Targeted Drug Discovery and Development Summit
7th RNA-Targeted Drug Discovery and Development Summit
10
Dec
2024
Free
Conferences
4th Applied Biocatalysis and Enzyme Engineering Summit
4th Applied Biocatalysis and Enzyme Engineering Summit
10
Dec
2024
Free
Conferences
Proteomic Based Drug Discovery Summit 2025
Proteomic Based Drug Discovery Summit 2025
11
Feb
2025

Proteomic Based Drug Discovery Summit 2025

Suffolk County, United States
Free
Conferences
Benefits of Signin
  • Publish Your Event for Free
  • Find Upcoming Events Near By
  • Grow Your B2B Network
  • Fix B2B Meeting Online/Event
  • Showcase Products to Right People